IL10 and neurodegenerative disease: Considering the previous observations, it seems that IL-10 must be correctly modulated in the context of neurodegenerative diseases, so that its production does not result in excessive quantities to prevent the elimination of potentially harmful agents and, at the same time, its levels are able to effectively balance the pro-inflammatory responses.